Discover 1,108 paid clinical trials in Hartford, Connecticut. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,108
Pragmatic Evaluation of Events And Benefits of Lipid-lowering in Older Adults
A Culturally-Tailored Mobile Health and Social Media Physical Activity Intervention for Improving Physical Activity in Hispanic or Latino/Latina Adolescent and Young Adult Childhood Cancer Survivors, Walking Juntos Study
for
Hematopoietic and Lymphatic System Neoplasm,
Location: New Haven CT, The Bronx NY, Hackensack NJ, Brooklyn NY,
Sponsor: Children's Oncology Group
Sex: All
Age: 15 - 20
Code: NCT06410209
Phase2, Recruiting
RESET-SSc: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201, a CD19-CAR T Cell Therapy, in Subjects With Systemic Sclerosis
Location: New Haven CT, Worcester MA, Darien CT, Providence RI,
Sponsor: M.A. Med Alliance S.A.
Sex: All
Age: 18+
Code: NCT05055297
Recruiting
Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)
Trial of Exercise and Lifestyle for Women With Ovarian and Endometrial Cancer
for
Ovarian Cancer
Location: New Haven CT, Miami FL
Sponsor: Yale University
Sex: Female
Age: 18+
Code: NCT05761561
Recruiting
Comparing Cooling and/or Compression Approaches of Limbs for Prevention of Chemotherapy-Induced Peripheral Neuropathy
for
Malignant Solid Neoplasm
Location: New Haven CT, Trumbull CT, Fairfield CT, Providence RI,
Sponsor: SWOG Cancer Research Network
Sex: All
Age: 18+
Code: NCT05642611
Phase3, Recruiting
Global Prospective, Observational Cohort of Adult Patients With Primary Sclerosing Cholangitis (WIND-PSC Study)
for
PSC
Location: New Haven CT, Boston MA, Montreal, Toronto, Richmond VA,
Sponsor: PSC Partners Seeking a Cure
Sex: All
Age: 18 - 70+
Code: NCT06297993
Recruiting
Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)